![Paul Burgess](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Burgess
Corporate Officer/Principal presso CEREVEL THERAPEUTICS HOLDINGS, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Posizioni attive di Paul Burgess
Società | Posizione | Inizio | Fine |
---|---|---|---|
CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 20/06/2023 | - |
Storia della carriera di Paul Burgess
Precedenti posizioni note di Paul Burgess
Società | Posizione | Inizio | Fine |
---|---|---|---|
TRANSLATE BIO, INC. | Direttore operativo | 11/12/2019 | 14/09/2021 |
Consigliere Generale | 01/03/2015 | 14/09/2021 | |
Segretario Aziendale | - | 14/09/2021 | |
Scholar Rock, Inc.
![]() Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2015 | 01/04/2016 |
DNIB UNWIND INC | Corporate Officer/Principal | 01/01/2008 | 01/07/2015 |
Civitas Therapeutics, Inc.
![]() Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Corporate Officer/Principal | 01/03/2011 | 01/02/2015 |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Consigliere Generale | - | - |
Logical Therapeutics, Inc.
![]() Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Formazione di Paul Burgess
Northeastern University | Graduate Degree |
Merrimack College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
Corporate Officer/Principal | 6 |
General Counsel | 2 |
Chief Operating Officer | 1 |
Settori
Health Technology | 9 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Translate Bio, Inc.
![]() Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Scholar Rock, Inc.
![]() Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
DNIB Unwind, Inc.
![]() DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Civitas Therapeutics, Inc.
![]() Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Logical Therapeutics, Inc.
![]() Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA. | Health Technology |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Paul Burgess
- Esperienza